Search research articles
Contact Us
Filters
Showing results (311-320 of 451) with videos related to
Page
of 46
Sort By:
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Hepatology Communications
|
March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Bertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Infectious Diseases and Therapy
|
April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Curtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
The New England Journal of Medicine
|
April 12, 2014
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
Jordan J Feld, Kris V Kowdley, Eoin Coakley, et al.
JCO Oncology Practice
|
June 14, 2022
Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer
Jessica P Hwang, Andy S Artz, Parth Shah, et al.
The American Journal of Gastroenterology
|
February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial
Jordan J Feld, Abdus S Wahed, Michael Fried, et al.
Hepatology (Baltimore, Md.)
|
April 17, 2024
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials
Muhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, et al.
Gastroenterology
|
September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
Jordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Gastroenterology
|
April 29, 2008
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease
Jordan J Feld, Nadeem Hussain, Elizabeth C Wright, et al.
Page
of 46
Search research articles
Search
Showing results (311-320 of 451) with videos related to
Sort By:
Page
of 46
CMAJ Open
|
December 27, 2016
Restrictions for reimbursement of direct-acting antiviral treatment for hepatitis C virus infection in Canada: a descriptive study
Alison D Marshall, Sahar Saeed, Lisa Barrett, et al.
Hepatology Communications
|
March 8, 2021
Efficacy and Safety of Cenicriviroc in Patients With Primary Sclerosing Cholangitis: PERSEUS Study
Bertus Eksteen, Christopher L Bowlus, Aldo J Montano-Loza, et al.
Infectious Diseases and Therapy
|
April 8, 2026
Efficacy and Safety of Glecaprevir/Pibrentasvir in Participants with Chronic HCV Infection and Comorbidities or Multiple Concomitant Medications: An Integrated Analysis
Curtis Cooper, Shweta A Raina, Lisa Johnson, et al.
Liver International : Official Journal of the International Association for the Study of the Liver
|
July 31, 2017
Sofosbuvir/velpatasvir in patients with hepatitis C virus genotypes 1-6 and compensated cirrhosis or advanced fibrosis
Tarik Asselah, Stefan Bourgeois, Stephen Pianko, et al.
The New England Journal of Medicine
|
April 12, 2014
Treatment of HCV with ABT-450/r-ombitasvir and dasabuvir with ribavirin
Jordan J Feld, Kris V Kowdley, Eoin Coakley, et al.
JCO Oncology Practice
|
June 14, 2022
Practical Implementation of Universal Hepatitis B Virus Screening for Patients With Cancer
Jessica P Hwang, Andy S Artz, Parth Shah, et al.
The American Journal of Gastroenterology
|
February 2, 2023
Withdrawal of Long-Term Nucleotide Analog Therapy in Chronic Hepatitis B: Outcomes From the Withdrawal Phase of the HBRN Immune Active Treatment Trial
Jordan J Feld, Abdus S Wahed, Michael Fried, et al.
Hepatology (Baltimore, Md.)
|
April 17, 2024
Neutralizing antibodies to interferon alfa arising during peginterferon therapy of chronic hepatitis B in children and adults: Results from the HBRN Trials
Muhammad Atif Zahoor, Joshua B Feld, Hsing-Hua Sylvia Lin, et al.
Gastroenterology
|
September 22, 2010
S-adenosyl methionine improves early viral responses and interferon-stimulated gene induction in hepatitis C nonresponders
Jordan J Feld, Apurva A Modi, Ramy El-Diwany, et al.
Gastroenterology
|
April 29, 2008
Hepatic involvement and portal hypertension predict mortality in chronic granulomatous disease
Jordan J Feld, Nadeem Hussain, Elizabeth C Wright, et al.
Page
of 46